Breast Cancer Therapy
Mount Vernon Hospital publishes research in breast cancer therapy
Published in OBGYN and Reproduction Week, October 8th, 2007
New research, 'Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer,' is the subject of a report. According to a study from Northwood, the United Kingdom, "A retrospective analysis was performed on 31 consecutive locally advanced or metastatic breast cancer patients who commenced exemestane 25mg/d orally following previous treatment with Tamoxifen and a non-steroidal third-generation aromatase inhibitor (AI). Patients were seen 3 monthly until clinical or radiological disease progression."
"Median age was 64 years (range 34-90 yrs). The average number of recurrences before starting exemestane was three (range 1-6)....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Breast Cancer
More Research Needed to Advance Knowledge of Sex Differences in Lung Cancer - Breast Cancer
Taxol-type Drugs Give Slight Boost to Survival Rates in Early Breast Cancer - Cancer Gene Therapy
Dr. Andrew I. Schafer Appointed Head of Department of Medicine at NYP/Weill Cornell - Cancer Vaccines
New Screening Guidelines for Women at High Risk for Breast Cancer - Endometrial Cancer
Internal radiotherapy better than external for quality of life in endometrial cancer patients - Menopause
Hormone therapy in early post-menopause has no effect on memory - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
